MedTrace Logo

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

NCT06401304 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-05-06

No results posted yet for this study

Summary

The study aspires to provide outcomes on surgery, quality of life and time-to-event outcomes following the development and validation of a standardised surgical assessment tool in a shared decision-making framework for patients with pre-invasive or invasive breast cancer with breast conservation.

Conditions

  • Breast Cancer
  • Breast Carcinoma in Situ
  • Breast Cancer Invasive
  • Breast Asymmetry

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER

  • Royal Marsden NHS Foundation Trust

    collaborator OTHER

  • Westmead Breast Cancer Institute, Sydney University, Sydney, Australia

    collaborator UNKNOWN

  • Breast Unit, University Campus Biomedico, Rome, Italy

    collaborator UNKNOWN

  • Uppsala University

    lead OTHER

Principal Investigators

  • Andreas Karakatsanis, MD, PhD · Uppsala University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2026-01-01
Completion
2032-12-30

Countries

  • Australia
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06401304 on ClinicalTrials.gov